Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Finasteride may increase suicide risk; more research needed.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Early balding at 40 increases prostate cancer risk.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

CT scans can find serious prostate cancer even when PSA levels are low.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Enriching the French health care database with external data greatly improved its usefulness.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.